HCA

SEC source: 0001193125-26-043139 · ownership.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 9

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By HD Trust

Disclosed balance after: 16,024

F8 · kind: Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 8

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,231

F8 · kind: Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 7

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,276

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.10 to $497.38, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 6

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,396

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.49 to $498.385, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 5

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,689

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.41 to $499.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 4

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,851

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.47 to $500.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 3

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,040

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.44 to $501.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,435

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.485 to $502.455, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,437

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.49 to $503.485, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-039795 · ownership.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,952.9017

SEC source: 0001193125-26-039795 · ownership.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,002.9017

SEC source: 0001193125-26-034005 · ownership.xml · derivative · entry 10

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 84,360 shares

Expires 2027-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

SEC source: 0001193125-26-034005 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,153

SEC source: 0001193125-26-034005 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-034009 · ownership.xml · derivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,560

Underlying: Common Stock · 2,560 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-034008 · ownership.xml · derivative · entry 1

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,067

Underlying: Common Stock · 8,067 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-034005 · ownership.xml · derivative · entry 9

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,846

Underlying: Common Stock · 55,846 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-034007 · ownership.xml · derivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,945

Underlying: Common Stock · 11,945 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-034000 · ownership.xml · derivative · entry 5

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,945

Underlying: Common Stock · 11,945 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-033998 · ownership.xml · derivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,067

Underlying: Common Stock · 8,067 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-26-033997 · ownership.xml · derivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,206

Underlying: Common Stock · 6,206 shares

Expires 2036-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

SEC source: 0001193125-25-286555 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,276

SEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 3

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,487

SEC source: 0001193125-25-267406 · ownership.xml · nonDerivative · entry 3

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001193125-25-267409 · ownership.xml · derivative · entry 6

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,170 shares

Expires 2032-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in two equal annual installments beginning on January 28, 2023.

SEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 2

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,379

SEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 1

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-25-267406 · ownership.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165

SEC source: 0001193125-25-267406 · ownership.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 43,240

SEC source: 0001193125-25-265148 · ownership.xml · derivative · entry 9

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,050 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.

SEC source: 0001193125-25-265148 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,106

SEC source: 0001193125-25-265148 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001632835-25-000003 · ownership.xml · nonDerivative · entry 3

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,502.9017

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025.

F2 · balance_after: Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0001632835-25-000003 · ownership.xml · derivative · entry 4

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,920 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025.

F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.

SEC source: 0001632835-25-000003 · ownership.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,338.9017

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025.

F2 · balance_after: Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0001632835-25-000003 · ownership.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,422.9017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025.

F2 · balance_after: Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-25-101052 · ownership.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496

F1 · kind: Represents common stock underlying 496 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0000950170-25-072916 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 Trust

Disclosed balance after: 93,088

SEC source: 0000950170-25-072916 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2022 GRAT

Disclosed balance after: 0

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 7

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By LCF Trust (Reporting Person, Trustee)

Disclosed balance after: 72,308

F2 · kind: Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 6

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

F2 · kind: Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 5

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By LCF Trust (Reporting Person, Trustee)

Disclosed balance after: 56,383

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 4

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 15,925

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 3

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By JMF Trust (Spouse and Robert Nagel, Co-Trustees)

Disclosed balance after: 67,595

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,566

SEC source: 0000950170-25-072914 · ownership.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,646

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.80 to $370.56, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 10

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 9

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 43,405

F2 · kind: Pursuant to a power of substitution, on May 7, 2025, the Reporting Person transferred 285 shares of common stock of the Issuer and cash to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $356.84 (the average of the high and low prices of shares of common stock of the Issuer on May 7, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 8

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ML Trust

Disclosed balance after: 0

F2 · kind: Pursuant to a power of substitution, on May 7, 2025, the Reporting Person transferred 285 shares of common stock of the Issuer and cash to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $356.84 (the average of the high and low prices of shares of common stock of the Issuer on May 7, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.